These data indicated that similar effects on RV-induced responses to those observed with neutrophil elastase inhibition could be induced by DNAse administration, supporting the mechanistic hypothesis that NETs induce downstream immunopathology through release of extracellular DNA which is therefore also a viable therapeutic target in COPD. Here, ELANE is linked to chronic obstructive pulmonary disease.